The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.

Revenue
+0.56%
EPS
+357.1%
Free cash flow
+66.0%
Total debt
+2.66%

Quarter to July 2026, against a year earlier

63.44 0.98 −1.52%
Market cap
$12.1B
P/E
21.7×
Fwd P/E
17.5×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
Piotroski F-Score
7 6 6 5

+8 more TTM periods

ROE
6.84% 2.85% 4.87% 4.59%
ROA
4.55% 1.89% 3.26% 3.03%
ROIC
3.17% 2.95% 4.15% 4.01%
Return on Tangible Assets
22.28% 8.97% 15.12% 12.19%
Average Days of Receivables
67.96 69.81 70.96 73.94
Free Cash Flow per Share
3.51 2.92 2.51 2.18
Free Cash Flow
678.00 569.50 491.20 433.70
Other line items

Show all line items

Columns are period end dates